Cubist Systematic Strategies’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,544
Closed -$384K 2915
2025
Q1
$384K Hold
3,544
﹤0.01% 2281
2024
Q4
$168K Sell
3,544
-11,612
-77% -$702K ﹤0.01% 2617
2024
Q3
$1.49M Buy
15,156
+1,740
+13% +$225K 0.01% 1591
2024
Q2
$2.19M Buy
13,416
+5,748
+75% +$819K 0.01% 1271
2024
Q1
$1.17M Buy
7,668
+5,888
+331% +$980K 0.01% 2042
2023
Q4
$558K Buy
+1,780
New +$644K ﹤0.01% 2462

Other funds holding AGL

Cubist Systematic Strategies's AGL Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Agilon Health (AGL) in Q3 2025, closing a stake of 30,037 shares — an estimated $1.73M sold.

Cubist Systematic Strategies first reported a position in AGL in Q2 2021 and held it in 12 quarters. The position peaked at $13.4M in Q3 2022. 190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Agilon Health position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 30,037 Agilon Health shares in Q3 2025, an estimated $1.73M.
  • Cubist Systematic Strategies first reported a position in Agilon Health in Q2 2021 and held it in 12 quarters.
  • Cubist Systematic Strategies's Agilon Health position peaked at $13.4M in Q3 2022.
  • 190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.